Pilot Survey to Assess International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Memorial Sloan Kettering Cancer Center1 site in 1 country26 target enrollmentApril 2010

ConditionsBreast Cancer Lymphoma

Overview

Phase: N/A
Intervention: Not specified
Conditions: Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Enrollment: 26
Locations: 1
Primary Endpoint: To determine the frequency of international travel of the targeted patients in the last 5 years.
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel.

Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.

Registry

clinicaltrials.gov

Start Date

April 2010

End Date

March 2012

Last Updated

13 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Memorial Sloan Kettering Cancer Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Hematopoietic Stem Cell Transplant (HSCT) recipients
•Age \>18 years
•Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3
•Female age \>18 years and current or past history of breast cancer
•Received systemic chemotherapy in the last five years
•Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3
•Age \>18 years and current or past history of lymphoma
•Received systemic chemotherapy within 5 years
•Had active disease at any time within the last 5 years

Exclusion Criteria

•Patients age\< 18 years
•Breast cancer and lymphoma patients in clinical remission in the past 5 years
•Patients unable to fill the questionnaire due to language barriers

Outcomes

Primary Outcomes

To determine the frequency of international travel of the targeted patients in the last 5 years.

Time Frame: once at the time of the clinic visit

Secondary Outcomes

To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised.(once at the time of the clinic visit)
To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics.(once at the time of the clinic visit)
To obtain detailed information about their last international trip including(once at the time of the clinic visit)
To assess the adequacy of the questionnaire instructions(once at the time of the clinic visit)